Gender-Based Dosing For Insomnia Drugs Dissected In NEJM
This article was originally published in The Pink Sheet Daily
Executive Summary
CDER officials explain the rationale behind new labeling on zolpidem-containing immediate- and controlled-release products that halves the recommended dose for women. Labeling changes include a new precaution against next-day driving following use of Sanofi’s Ambien CR.